Email updates

Keep up to date with the latest news and content from Breast Cancer Research and BioMed Central.

This article is part of the supplement: Royal College of Radiologists Breast Group Annual Scientific Meeting 2010

Open Badges Oral presentation

MR visible only lesions: what are the predictors for malignant outcome?

M Bhattacharyya*, F Ng and W Teh

  • * Corresponding author: M Bhattacharyya

Author Affiliations

Northwick Park Hospital, Harrow, UK

For all author emails, please log on.

Breast Cancer Research 2010, 12(Suppl 3):O5  doi:10.1186/bcr2652

The electronic version of this article is the complete one and can be found online at:

Published:25 October 2010

© 2010 Bhattacharyya et al; licensee BioMed Central Ltd.


To correlate pathological outcomes of MRI vacuum biopsies on MRI visible only breast lesions with lesion morphology, time-enhancement curves and clinical indications to determine the use of these as predictors for malignancy.


A retrospective analysis of 277 patients referred for MRI-guided vacuum biopsies of impalpable breast lesions visible only on MRI was performed. All patients had a minimum follow-up period of 11 months. MRI biopsies were undertaken on a 1.5 T magnet using a minimum of 12 passes of vacuum-assisted biopsies. The pathological findings were correlated against BI-RADS appearances and time-enhancement characteristic of the lesions and against the clinical indications for MRI examination.


A total of 286 vacuum biopsies were undertaken. Eighty-one were malignant (28.3%), of which 72.8% are masses and 27.2% are nonmasses. Only two malignant lesions had a type 1 curve (2.5%), compared with malignant lesions with type 2 (54.3%) and type 3 curves (43.2%). Both malignant lesions with type 1 curve had a suspicious morphology. Nonmalignant lesions with type 3 enhancement included lymph nodes, fibroadenomatoid hyperplasia, papillary lesions, fibrocystic change and lobular neoplasia.


Lesion morphology and time-enhancement curves are useful predictors of malignancy and can be used to develop an algorithm to help direct appropriate biopsy of MRI-detected lesions. We recommend that in the absence of suspicious morphology, only lesions with type 2 and type 3 curves should be subjected to MRI-guided biopsy.